21 Cathie Wood CRISPR Therapeutics AG Trades
Cathie Wood's position in CRISPR Therapeutics AG is currently worth $413 Million. That's 2.85% of their equity portfolio (11th largest holding). The investor owns 10.46% of the outstanding CRISPR Therapeutics AG stock. The first CRISPR Therapeutics AG trade was made in Q2 2017. Since then Cathie Wood bought shares fifteen more times and sold shares on seven occasions. The investor's estimated purchase price is $571 Million, resulting in a loss of 28%.
News about CRISPR Therapeutics AG and Cathie Wood
Why This Analyst Sees A 51% Return On This Cathie Wood-Favored Biotech Stock
Biotech stocks have the potential for huge gains if a product or drug is deemed effective and safe, but investing in the shares of those companies can be vol...
5 Top Stocks Cathie Wood Bought This Week
Source: rhendrikdwenz via Shutterstock So far, 2022 has been a rocky year for Cathie Wood’s exchange-traded funds (ETFs). Her flagship fund, the ARK Innovati...